Literature DB >> 9729522

Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection.

J L Fahey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9729522      PMCID： PMC95626          DOI： 10.1128/CDLI.5.5.597-603.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  89 in total

1.  Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic staging.

Authors:  B Hofmann; I Bygbjerg; E Dickmeiss; V Faber; B Frederiksen; J Gaub; J Gerstoft; B K Jakobsen; K D Jakobsen; B O Lindhardt
Journal:  Scand J Infect Dis       Date:  1989

2.  Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals.

Authors:  J Homsy; M Meyer; J A Levy
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.

Authors:  P Nishanian; K R Huskins; S Stehn; R Detels; J L Fahey
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

Review 4.  AIDS as immune system activation. II. The panergic imnesia hypothesis.

Authors:  M S Ascher; H W Sheppard
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  The initial immune response to HIV and immune system activation determine the outcome of HIV disease.

Authors:  H W Sheppard; M S Ascher; B McRae; R E Anderson; W Lang; J P Allain
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

6.  Immune activation markers and AIDS prognosis.

Authors:  D H Osmond; S Shiboski; P Bacchetti; E E Winger; A R Moss
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

7.  CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.

Authors:  R Yarchoan; D J Venzon; J M Pluda; J Lietzau; K M Wyvill; A A Tsiatis; S M Steinberg; S Broder
Journal:  Ann Intern Med       Date:  1991-08-01       Impact factor: 25.391

8.  Immune activation markers to predict AIDS and survival in HIV-1 seropositives.

Authors:  D Fuchs; H Jäger; M Popescu; G Reibnegger; E R Werner; M P Dierich; W Kaboth; G P Tilz; H Wachter
Journal:  Immunol Lett       Date:  1990-10       Impact factor: 3.685

9.  Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.

Authors:  B Hofmann; Y X Wang; W G Cumberland; R Detels; M Bozorgmehri; J L Fahey
Journal:  AIDS       Date:  1990-03       Impact factor: 4.177

10.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245
View more
  22 in total

Review 1.  Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects.

Authors:  P De Paoli
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

Authors:  Robert C Kalayjian; Rhoderick N Machekano; Nesrine Rizk; Gregory K Robbins; Rajesh T Gandhi; Benigno A Rodriguez; Richard B Pollard; Michael M Lederman; Alan Landay
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 3.  Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infection.

Authors:  Nikolaos V Sipsas; Petros P Sfikakis
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Different profile of cytokine synthesis according to the severity of acute pancreatitis.

Authors:  Raquel Laveda; Juan Martinez; Carlos Munoz; Juan-Carlos Penalva; Jesus Saez; German Belda; Salvador Navarro; Faust Feu; Anton Mas; Jose-Ma Palazon; Jose Sanchez-Paya; Jose Such; Miguel Perez-Mateo
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

5.  In vivo production of type 1 cytokines in healthy sickle cell disease patients.

Authors:  S C Taylor; S J Shacks; Z Qu
Journal:  J Natl Med Assoc       Date:  1999-11       Impact factor: 1.798

6.  Inflammation and Risk of Depression in HIV: Prospective Findings From the Multicenter AIDS Cohort Study.

Authors:  Haidong Lu; Pamela J Surkan; Michael R Irwin; Glenn J Treisman; Elizabeth C Breen; Ned Sacktor; Ron Stall; Steven M Wolinsky; Lisa P Jacobson; Alison G Abraham
Journal:  Am J Epidemiol       Date:  2019-11-01       Impact factor: 4.897

7.  Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2.

Authors:  P De Paoli; S Zanussi; L Caggiari; M T Bortolin; M D'Andrea; C Simonelli; U Tirelli
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

8.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.

Authors:  Jason M Brenchley; Mirko Paiardini; Kenneth S Knox; Ava I Asher; Barbara Cervasi; Tedi E Asher; Phillip Scheinberg; David A Price; Chadi A Hage; Lisa M Kholi; Alexander Khoruts; Ian Frank; James Else; Timothy Schacker; Guido Silvestri; Daniel C Douek
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

9.  Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.

Authors:  Melissa E Schechter; Bruno B Andrade; Tianyu He; George Haret Richter; Kevin W Tosh; Benjamin B Policicchio; Amrit Singh; Kevin D Raehtz; Virginia Sheikh; Dongying Ma; Egidio Brocca-Cofano; Cristian Apetrei; Russel Tracy; Ruy M Ribeiro; Alan Sher; Ivo M B Francischetti; Ivona Pandrea; Irini Sereti
Journal:  Sci Transl Med       Date:  2017-08-30       Impact factor: 17.956

10.  Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions.

Authors:  Najib Aziz; Roger Detels; Joshua J Quint; Qian Li; David Gjertson; Anthony W Butch
Journal:  Cytokine       Date:  2016-05-18       Impact factor: 3.861
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.